Prosecution Insights
Last updated: October 02, 2026

Fenwal Inc.

Technology area: Medical Devices & Mechanical Engineering

15 pending office actions • 8 art units • 15 examiners • 0 of 15 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days

Analysis

Fenwal Inc. manages a portfolio with 17 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 17 distinct examiners and 9 distinct art units. EDWARDS, LOREN C is the busiest examiner, currently handling 1 pending office action.

The prosecution is highly decentralized, as 17 distinct examiners are each reviewing only one of the pending office actions. This extreme dispersion means that the company must manage separate prosecution tracks, each with its own examiner preferences and timelines. The involvement of 9 distinct art units indicates a broad technical range within the company's medical and mechanical filings, requiring expertise across many different sections of the patent office.

EDWARDS, LOREN C is responsible for 1 pending office action, reflecting the wide spread of work across the examiner pool. With 17 distinct examiners and 9 distinct art units involved, no single official or technical group dominates the company's current workload. This structure minimizes the impact of any one examiner's hurdles but also requires a highly coordinated effort to maintain consistency across the pending office actions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

15
Total Pending OAs
7
Non-Final OAs
7
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (47%)
8
Medium (53%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (7%)
§103 only7 (47%)
§102 only1 (7%)
Multi-statute (no §101)6 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
27% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
7% of docket
6
Mechanical / Eng
40% of docket
4
Business / Other
27% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

150 h
Manual time on pending OAs
30 h
Time saved (low, 20%)
52 h
Time saved (mid, 35%)
1.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LE, QUYNH DAO 1 34.8% +10.1%
HAN, SETH 1 59.6% +28.8%
LANGE, ERIC A 1 77.5% +12.4%
NAJARIAN, LENA 1 38.9% +39.2%
MARCETICH, ADAM M 1 72.7% +18.8%
COOLEY, CHARLES E 1 79.0% +15.2%
JEONG, YOUNGSUL 1 71.5% +21.6%
TOWNSEND, GUY K 1 74.3% +25.3%
MENON, KRISHNAN S 1 59.7% +11.7%
OSINSKI, BRADLEY JAMES 1 78.5% +11.3%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18181023 OPTIMIZATION OF FLUID POOLING MARTIN, PAUL C 23d overdue
18378679 Systems And Methods For Collecting A Platelet Product Having A Target Concentration MENON, KRISHNAN S 16d
18119945 REVERSIBLE STERILE CONNECTION SYSTEM OSINSKI, BRADLEY JAMES 70d
18646247 BEDSIDE CELL PROCESSING SYSTEM HAVING A REINFUSION SYSTEM LANGE, ERIC A —
18420050 Packaging Tray for a Blood Processing Kit COOLEY, CHARLES E —
18539366 Direct Drive Centrifuge JEONG, YOUNGSUL —
17937476 Detection Of Data Entry Errors For Blood Separation Systems KALIHER, HANS CHRISTIAN —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18378679 Systems And Methods For Collecting A Platelet Product Having A Target Concentration MENON, KRISHNAN S 16d
18119945 REVERSIBLE STERILE CONNECTION SYSTEM OSINSKI, BRADLEY JAMES 70d
18388871 Maximization Of Plasma Collection And Collection Of Buffy Coat Or White Blood Cell Layer Using Collected Plasma TOWNSEND, GUY K 75d
18920829 THERAPEUTIC PLASMA EXCHANGE METHODS AND APHERESIS KIT FOR FLUSH AND DIVERT PRIME STAGE WHEN USING AN ADSORPTION COLUMN LE, QUYNH DAO —
18882466 Methods and Systems for Collecting Whole Blood from a Donor and Maintaining Fluid Volume HAN, SETH —
18646247 BEDSIDE CELL PROCESSING SYSTEM HAVING A REINFUSION SYSTEM LANGE, ERIC A —
18631510 Device Screen Interaction Using a Scanner and Bidirectional Data Transfer NAJARIAN, LENA —
18618801 Systems and Methods For Controlling The Risk Of Citrate Reactions During Apheresis MARCETICH, ADAM M —

Top Art Units

Art UnitApps
3781 3
1653 2
3687 1
1772 1
1777 1
3783 1
2877 1
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18920829 THERAPEUTIC PLASMA EXCHANGE METHODS AND APHERESIS KIT FOR FLUSH AND DIVERT PRIME STAGE WHEN USING AN ADSORPTION COLUMN LE, QUYNH DAO — §103 Non-Final OA — Pending Oct 18, 2024
18882466 Methods and Systems for Collecting Whole Blood from a Donor and Maintaining Fluid Volume HAN, SETH — §103 Non-Final OA — Pending Sep 11, 2024
18646247 BEDSIDE CELL PROCESSING SYSTEM HAVING A REINFUSION SYSTEM LANGE, ERIC A — §102§103§112 Non-Final OA — Pending Apr 25, 2024
18631510 Device Screen Interaction Using a Scanner and Bidirectional Data Transfer NAJARIAN, LENA 3687 §103 Non-Final OA — Pending Apr 10, 2024
18618801 Systems and Methods For Controlling The Risk Of Citrate Reactions During Apheresis MARCETICH, ADAM M 3781 §103 Final Rejection — Pending Mar 27, 2024
18420050 Packaging Tray for a Blood Processing Kit COOLEY, CHARLES E — §102§103 Non-Final OA — Pending Jan 23, 2024
18539366 Direct Drive Centrifuge JEONG, YOUNGSUL 1772 §102§103 Non-Final OA — Pending Dec 14, 2023
18388871 Maximization Of Plasma Collection And Collection Of Buffy Coat Or White Blood Cell Layer Using Collected Plasma TOWNSEND, GUY K 3781 §102 Final Rejection 75d Pending Nov 13, 2023
18378679 Systems And Methods For Collecting A Platelet Product Having A Target Concentration MENON, KRISHNAN S 1777 §102§103 Final Rejection 16d Pending Oct 11, 2023
18119945 REVERSIBLE STERILE CONNECTION SYSTEM OSINSKI, BRADLEY JAMES 3783 §103§112 Non-Final OA 70d Pending Mar 10, 2023
18181023 OPTIMIZATION OF FLUID POOLING MARTIN, PAUL C 1653 §101 Final Rejection 23d overdue Pending Mar 09, 2023
18101275 Determination Of The Concentration Of One Or More Substances In A Fluid CARLSON, JOSHUA MICHAEL 2877 §103 Final Rejection 30d overdue Pending Jan 25, 2023
17937476 Detection Of Data Entry Errors For Blood Separation Systems KALIHER, HANS CHRISTIAN 3781 §102§103 Non-Final OA — Pending Oct 03, 2022
16720840 Methods and Systems for Platelet Cryopreservation TICHY, JENNIFER M.H. 1653 §103 Final Rejection 22d overdue Pending Dec 19, 2019
16488822 Sample Tube Holder And System And Method Employing Same ROBERTS, ANNA L 3791 §103 Final Rejection — Pending Aug 26, 2019

Managing Fenwal Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month